,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', '$azn']
#asco22: enhertu blows chemotherapy out of the water, redefining breast cancer subgroups along the way
(a legacy of the late jose baselga's turn at $azn) 
Founder, EIC of Endpoints News: The biopharma world is here -- 144,000 global industry subscribers. We work for it. #sweatequity john@endpointsnews.com